{"title":"The value of cardiopulmonary ultrasound in diagnosing cardiogenic pulmonary edema in patients with heart failure.","authors":"Yanfen Zhong, Jie Shen, Jingtao Li, Hongyu Zheng","doi":"10.3389/fmed.2026.1938070","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Heart failure (HF) is generally complicated with cardiogenic pulmonary edema (CPE), the early diagnosis and treatment is essential. We aimed to evaluate the effects of cardiopulmonary ultrasound (CPUS) in the diagnosis of CPE in HF patients, to provide reference for the management of HF.</p><p><strong>Methods: </strong>HF patients entering The People's Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences intensive care unit (ICU) between March 2025 and July 2026 were included. All patients underwent CPUS and chest computed tomography (CT), and comparison of the detection rates of cardiogenic pulmonary edema between CPUS and CT.</p><p><strong>Results: </strong>A total of 117 patients with HF were enrolled in this study. Of the 117 HF patients, 46 were diagnosed with CPE, and 43 were correctly diagnosed by CT, with a diagnostic accuracy of 94.9%, the positive predictive value (PPV) was 93.5%, the negative predictive value (NPV) was 95.8%, the sensitivity was 93.5%, the specificity was 95.8%, the positive likelihood ratio (PLR) was 22, and the negative likelihood ratio (NLR) was 0.07. While 41 were correctly diagnosed by CPUS, with a diagnostic accuracy of 92.3%, the PPV was 91.1%, NPV was 93.1%, the sensitivity was 89.1%, the specificity was 94.3%, the PLR was 16, and the NLR was 0.12. Comparison of CT and CPUS in the diagnosis of CPE, there was no statistically significant difference between the two methods (<i>X</i> <sup>2</sup> = 0.111, <i>P</i> > 0.05). And The Cohen's kappa for the diagnosis of CPE by CT and CPUS is 0.873 (95% CI was 0.782-0.963, <i>P <</i> 0.001).</p><p><strong>Conclusions: </strong>In conclusion, the present study suggests that CPUS is feasible for identifying cardiogenic pulmonary edema in ICU patients with heart failure. Based on diagnostic agreement analysis, CPUS demonstrates promising performance for CPE detection in this critically-ill cohort.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1938070"},"PeriodicalIF":3.6000,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13677347/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2026.1938070","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Heart failure (HF) is generally complicated with cardiogenic pulmonary edema (CPE), the early diagnosis and treatment is essential. We aimed to evaluate the effects of cardiopulmonary ultrasound (CPUS) in the diagnosis of CPE in HF patients, to provide reference for the management of HF.
Methods: HF patients entering The People's Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences intensive care unit (ICU) between March 2025 and July 2026 were included. All patients underwent CPUS and chest computed tomography (CT), and comparison of the detection rates of cardiogenic pulmonary edema between CPUS and CT.
Results: A total of 117 patients with HF were enrolled in this study. Of the 117 HF patients, 46 were diagnosed with CPE, and 43 were correctly diagnosed by CT, with a diagnostic accuracy of 94.9%, the positive predictive value (PPV) was 93.5%, the negative predictive value (NPV) was 95.8%, the sensitivity was 93.5%, the specificity was 95.8%, the positive likelihood ratio (PLR) was 22, and the negative likelihood ratio (NLR) was 0.07. While 41 were correctly diagnosed by CPUS, with a diagnostic accuracy of 92.3%, the PPV was 91.1%, NPV was 93.1%, the sensitivity was 89.1%, the specificity was 94.3%, the PLR was 16, and the NLR was 0.12. Comparison of CT and CPUS in the diagnosis of CPE, there was no statistically significant difference between the two methods (X2 = 0.111, P > 0.05). And The Cohen's kappa for the diagnosis of CPE by CT and CPUS is 0.873 (95% CI was 0.782-0.963, P < 0.001).
Conclusions: In conclusion, the present study suggests that CPUS is feasible for identifying cardiogenic pulmonary edema in ICU patients with heart failure. Based on diagnostic agreement analysis, CPUS demonstrates promising performance for CPE detection in this critically-ill cohort.
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world